WKN DE: A2AT0Z / ISIN: CH0334081137

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

CRISPR Therapeutics Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)
20:18:01	47,585
20:02:41	47,750
19:33:49	47,915
19:18:09	47,995
19:04:04	48,010
18:34:40	47,695
18:31:16	47,710
18:16:25	47,535
18:15:33	47,780	21
18:15:31	47,780	21
18:01:27	47,630
17:31:32	47,665
17:16:30	48,050
17:01:41	48,620
16:31:46	48,740
16:16:37	48,805
16:09:41	48,760	221
15:31:43	46,950
15:16:52	46,500
15:01:45	46,500
14:31:44	46,745
14:16:49	46,745
13:31:33	46,820
13:17:02	46,490
13:02:16	46,485
12:51:35	46,495
12:32:14	46,470
12:17:06	46,455
12:10:34	46,445	20
12:10:31	46,445	20
12:02:19	46,445
11:32:23	46,460
11:17:17	46,450
11:02:51	45,980
10:33:00	46,035

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu CRISPR Therapeutics AG

Weitere Meldungen

20:23		SpaceX stock’s wild price swings since its IPO show how risky leveraged ETFs can be
20:19		Curacao's trailblazing doctor at the World Cup
20:00		UK tax loophole used by Shein will not be closed until October 2028
20:00		3D-Drucker-Deals: Die besten Schnäppchen zum Prime Day - Bambu günstig wie nie
19:51		Meta halts worker tracking for AI training due to privacy fears
19:48		SpaceX pitches investors juicy yields in $25bn bond deal
19:48		SpaceX pitches investors juicy yields in $25bn bond deal
19:46		Lockheed Martin Stock Is Down 6% in 2 Days. Here's What Investors Need to Know
19:46		Here's Why Shares in Vertiv Crashed Today
19:45		Your index fund is hiding a looming tech-stock risk — here is how to protect your portfolio
19:41		Archer Aviation vs. Boeing: Is an Upstart or Established Aerospace Stock the Better Buy in 2026?
19:31		Prediction: You Won't Recognize Enbridge in 15 Years. Here's Why.
19:29		Eli Lilly and Bayer hit out at Germany’s spending on new medicines
19:29		Eli Lilly and Bayer hit out at Germany’s spending on new medicines
19:26		SpaceX Is Pulling Back. These 3 Stocks Are the Biggest Beneficiaries.
19:25		US Supreme Court limits scope of foreign human rights claims
19:23		Why Bloom Energy Stock Tumbled Today
19:22		Why Royal Caribbean Stock Dropped, Then Popped
19:21		Carnival’s Record Quarter Gets Sunk By Middle East Worries
19:19		Ford and General Motors Want In on the Energy Craze. Which Stock Will Win?
19:11		AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst
19:11		Adobe vs. Duolingo: Which Technology Stock Is a Better Buy in 2026?
19:04		Trump admits selling IBM’s stock was a mistake. Now he’s cheering its quantum future.
19:01		Nio Shares Edge Higher Tuesday: What's Going On?
18:59		Why Is Natera Stock Gaining Tuesday?
18:59		Interest Rates Are Likely to Rise This Year. Here's What That Could Mean for the S&P 500
18:48		SpaceX Dropped Sharply on Monday. Is It Worth Buying the Dip?
18:47		Stock Market Today, June 23: Sandisk Leads Tech Stock Slide as South Korea Jitters Trigger Global Pullback at Midday
18:47		SpaceX Stock Is Down 35% From Its Peak and Back Near Its IPO Price. Is It Time to Buy the Dip?
18:45		Here’s How Much You Would Have Made Owning State Street SPDR Portfolio S&P 500 Growth ETF Stock In The Last 15 Years
18:45		Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today
18:39		Why Is AST SpaceMobile Stock Gaining Tuesday?
18:30		Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today
18:27		Oklo Stock Is Rising Despite Tuesday’s Market Selloff: What's Going On?
18:27		SpaceX tests its reality-warping powers on the bond market
18:27		SpaceX tests its reality-warping powers on the bond market
18:23		Cheaper Jet Fuel, Golden Cross And A Breakout: Is American Airlines Stock Ready For Takeoff?
18:19		Colombia: The 'Tiger's' victory signals a rightward shift
18:18		Apple Just Closed Its First Unionized U.S. Store
18:16		If You Invested $100 In Lockheed Martin Stock 20 Years Ago, You Would Have This Much Today
18:16		Bitcoin Has Been Cut In Half, But MARA And HIVE Just Flashed Golden Crosses
18:14		3 Screaming Buy Artificial Intelligence (AI) Stocks Set for a Massive Summer Rebound
18:11		Private Credit Pressure Builds As Apollo Limits Redemptions For Second Straight Quarter
18:10		Down Nearly 50% From Its High, Is Super Micro Computer Stock a Bargain Buy?
18:05		How XOVR Turned SpaceX IPO Into A Test Case For Private-Market ETF Investing
18:01		Energy Fuels buys German magnet maker for $1.9bn
18:01		Bitcoin Could Start A Catch-Up Rally—But The Fed Has To Play Ball, Bitwise's Matt Hougan Says
18:00		Here's How Much $1000 Invested In S&P Global 10 Years Ago Would Be Worth Today
18:00		What Is Going On With Marvell Stock On Tuesday?
18:00		Micron Technology Has Made a Terrific Move Before Its June 24 Earnings Report

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Globus Maritime Viji Finance OMV Petrom CybAero AB Registered Shs Issue 2016 Sunil Hitech Engineers

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	23.06.2026 20:30
Kaufwert:	EUR
	Hinzufügen Speichern

CRISPR Therapeutics Aktie

WKN DE: A2AT0Z / ISIN: CH0334081137

CRISPR Therapeutics Times and Sales (STU)

Analysen zu CRISPR Therapeutics AG

Weitere Meldungen